enGene Therapeutics ENGN
NASDAQ ENGN
$2.00 +0.05 (+2.56%)
At close: Sep 30, 2026 · 4:00 PM EDT

enGene Therapeutics (ENGN) Total Debt (2022 - 2026)

Updated

enGene Therapeutics (ENGN) recorded Total Debt of $25.35 million in fiscal Q3 2026 (quarter ended Jul 31, 2026), up 9.7% from $23.12 million a year earlier and up 1.0% from the prior quarter.

Analysis

enGene Therapeutics (ENGN) Total Debt (2022 - 2026) Analysis & Trends

At the end of FY2025 (ended Oct 31, 2025), enGene Therapeutics reported Total Debt of $23.33 million, up 0.7% from FY2024.

  • Annual Total Debt has a three-year compound annual growth rate of 28.8% (FY2022 to FY2025).
  • Across earlier fiscal years, Total Debt came in at $23.17 million in FY2024 (+137.0%), $9.78 million in FY2023 (-10.4%) and $10.91 million in FY2022.
  • The fiscal Q3 2026 figure is the highest quarterly Total Debt since fiscal Q3 2023.
  • On a year-over-year basis, Total Debt has increased for eight consecutive quarters, with growth averaging 21.1% over the last eight quarters.
  • Peak year-over-year performance for Total Debt in the last five years was growth of 137.0% in fiscal Q4 2024, against a decline of 42.6% in fiscal Q3 2024 at the low end.
  • Per Business Quant, the preceding three fiscal quarters came in at $25.1 million (Q2 2026), $24.92 million (Q1 2026) and $23.33 million (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Debt (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 49.04 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 70.82 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 53.91 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 37.49 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -111.00 Mn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 57.30 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 26.25 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 63.19 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 enGene Therapeutics 134.03 Mn 134.03 Mn - 25.35 Mn
Historic Data

Historic Data

Download Data
DateValue
Jul 31, 2026 25.35 Mn
Apr 30, 2026 25.10 Mn
Jan 31, 2026 24.92 Mn
Oct 31, 2025 23.33 Mn
Jul 31, 2025 23.12 Mn
Apr 30, 2025 23.59 Mn
Jan 31, 2025 23.39 Mn
Oct 31, 2024 23.17 Mn
Jul 31, 2024 22.95 Mn
Apr 30, 2024 22.73 Mn
Jan 31, 2024 22.53 Mn
Oct 31, 2023 9.78 Mn
Jul 31, 2023 39.99 Mn
Oct 31, 2022 10.91 Mn
API Access

enGene Therapeutics Total Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-debt&ticker=ENGN&period=max&api_key=YOUR_API_KEY